Teresa Maria Sorbo

Department of Translational Medical Sciences, University of Naples Federico II, Naples, Italy.

1 publication 2021 – 2021
COVID-19ItalyImmunoassayImmunoglobulin MLuminescence

What does Teresa Maria Sorbo research?

Teresa Maria Sorbo studies how well different blood tests can detect antibodies to SARS-CoV-2, the virus responsible for COVID-19. By analyzing the results of multiple testing methods, she helps to determine how many people in specific regions have had prior infections. This research is crucial during pandemics because understanding the level of past infections can help inform public health responses and vaccination strategies.

Key findings

  • In a study involving 3,185 participants, about 2% were found to have been infected with COVID-19, which highlighted the low infection rate at the time and explained the virus's widespread nature during the second wave.
  • Five different blood testing methods showed consistent results, proving that they can be reliable for detecting past infections, which is important for public health monitoring.
  • The comparison of the five tests revealed that most performed well, allowing for confidence in using these antibody tests for tracking infection rates in the community.

Frequently asked questions

Does Dr. Sorbo study COVID-19?
Yes, Dr. Teresa Maria Sorbo focuses on COVID-19, particularly the testing of blood samples to detect past infections.
What treatments has Dr. Sorbo researched?
Dr. Sorbo's research primarily involves testing methods rather than specific treatments for COVID-19.
Is Dr. Sorbo's work relevant to understanding COVID-19 infection rates?
Absolutely, her research directly contributes to understanding how many people have been infected with COVID-19 in different populations.

Publications in plain English

Seroprevalence of SARS-CoV-2 Assessed by Four Chemiluminescence Immunoassays and One Immunocromatography Test for SARS-Cov-2.

2021

Frontiers in public health

Cerino P, Gallo A, Pierri B, Buonerba C, Di Concilio D +20 more

Plain English
Researchers tested 3,185 people in Italy using five different blood tests to detect antibodies showing they had been infected with COVID-19, comparing how well these tests matched each other's results. Most tests performed well and gave similar results, finding that about 2% of the population had been infected—a very low rate that explained why COVID was spreading so widely in the second wave. This comparison was important because these antibody tests were new and needed to be proven reliable before being used to track how many people in the community had actually had COVID.

PubMed

Publication data sourced from PubMed . Plain-English summaries generated by AI. Not medical advice.